ASTRAZENECA PHARMACEUTICALS Gains $855 Million Contract Modification
Copyright © Targeted News Service 2022
2022-02-17
WASHINGTON, Feb. 17 -- The U.S. Army Contracting Command issued the following high-value contract information through the Pentagon on Feb. 11, 2022:
ASTRAZENECA PHARMACEUTICALS LP, Wilmington, Delaware, was awarded an $855,000,000 modification to a contract (W911QY-20-C-0119) for the manufacture, distribution and storage of AZD7442, known as Evusheld, to treat COVID-19 in the general population.
The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is t . . .
ASTRAZENECA PHARMACEUTICALS LP, Wilmington, Delaware, was awarded an $855,000,000 modification to a contract (W911QY-20-C-0119) for the manufacture, distribution and storage of AZD7442, known as Evusheld, to treat COVID-19 in the general population.
The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is t . . .